Clinical Trial Update: Effects of Acthar on Recovery From Cognitive Relapses in MS [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Acthar for recovery from cognitive relapses in multiple sclerosis has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Acthar (repository corticotropin injection)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2020-04-06